By Helgi Analytics - October 8, 2022
Zur Rose employed 2,131 employees in 2021, up 8.72% compared to the previous year. Historically, between 2009 and 2021,...
By Helgi Analytics - October 8, 2022
Zur Rose made a net profit of CHF -226 mil with revenues of CHF 1,727 mil in 2021, down by 66.4% and up by 16.9%, r...
By Helgi Analytics - October 8, 2022
Zur Rose stock traded at CHF 236 per share at the end 2021 translating into a market capitalization of USD 2,648 mil. Since the e...
| Profit Statement | 2019 | 2020 | 2021 | |
| Sales | CHF mil | 1,356 | 1,477 | 1,727 |
| Gross Profit | CHF mil | 209 | 251 | 263 |
| EBITDA | CHF mil | -13.8 | -78.4 | -143 |
| EBIT | CHF mil | -45.7 | -118 | -194 |
| Financing Cost | CHF mil | 4.40 | 13.5 | 14.9 |
| Pre-Tax Profit | CHF mil | -50.1 | -133 | -227 |
| Net Profit | CHF mil | -52.4 | -136 | -226 |
| Dividends | CHF mil | 0 | 0 | 0 |
| Balance Sheet | 2019 | 2020 | 2021 | |
| Total Assets | CHF mil | 992 | 1,278 | 1,269 |
| Non-Current Assets | CHF mil | 564 | 739 | 732 |
| Current Assets | CHF mil | 428 | 539 | 537 |
| Working Capital | CHF mil | 105 | 115 | 92.3 |
| Shareholders' Equity | CHF mil | 406 | 532 | 485 |
| Liabilities | CHF mil | 586 | 747 | 784 |
| Total Debt | CHF mil | 438 | 571 | 569 |
| Net Debt | CHF mil | 233 | 270 | 291 |
| Ratios | 2019 | 2020 | 2021 | |
| ROE | % | -12.3 | -29.0 | -44.4 |
| ROCE | % | -9.90 | -17.8 | -26.9 |
| Gross Margin | % | 15.4 | 17.0 | 15.2 |
| EBITDA Margin | % | -1.02 | -5.31 | -8.26 |
| EBIT Margin | % | -3.37 | -7.96 | -11.2 |
| Net Margin | % | -3.86 | -9.19 | -13.1 |
| Net Debt/EBITDA | -16.8 | -3.44 | -2.04 | |
| Net Debt/Equity | % | 57.4 | 50.7 | 60.0 |
| Cost of Financing | % | 1.50 | 2.67 | 2.62 |
| Valuation | 2019 | 2020 | 2021 | |
| Market Capitalisation | USD mil | 961 | 3,060 | 2,648 |
| Enterprise Value (EV) | USD mil | 1,202 | 3,365 | 2,966 |
| Number Of Shares | mil | 8.66 | 9.08 | 9.65 |
| Share Price | CHF | 107 | 283 | 236 |
| EV/EBITDA | -84.8 | -39.7 | -18.7 | |
| EV/Sales | 0.866 | 2.11 | 1.54 | |
| Price/Earnings (P/E) | -17.7 | -18.9 | -10.1 | |
| Price/Book Value (P/BV) | 2.29 | 4.83 | 4.68 | |
| Dividend Yield | % | 0 | 0 | 0 |
Get all company financials in excel:
| overview | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| income statement | ||||||||||||||||||||
| Sales | CHF mil | 834 | 880 | 983 | 1,207 | 1,356 | ||||||||||||||
| Gross Profit | CHF mil | 125 | 132 | 147 | 181 | 209 | ||||||||||||||
| EBIT | CHF mil | 8.44 | -7.09 | -38.3 | -32.9 | -45.7 | ||||||||||||||
| Net Profit | CHF mil | 3.45 | -12.8 | -36.2 | -39.0 | -52.4 | ||||||||||||||
| ROE | % | ... | 4.59 | -14.5 | -18.2 | -10.6 | -12.3 | |||||||||||||
| EBIT Margin | % | 1.01 | -0.806 | -3.90 | -2.72 | -3.37 | ||||||||||||||
| Net Margin | % | 0.413 | -1.45 | -3.69 | -3.23 | -3.86 | ||||||||||||||
| Employees | 716 | 752 | 1,106 | 1,314 | 1,710 | ... | ... | ... | ... | ... | ... | |||||||||
| balance sheet | ||||||||||||||||||||
| Total Assets | CHF mil | 233 | 262 | 462 | 727 | 992 | ||||||||||||||
| Non-Current Assets | CHF mil | 91.1 | 102 | 188 | 310 | 564 | ||||||||||||||
| Current Assets | CHF mil | 142 | 160 | 273 | 417 | 428 | ||||||||||||||
| Shareholders' Equity | CHF mil | 72.8 | 104 | 294 | 444 | 406 | ||||||||||||||
| Liabilities | CHF mil | 161 | 158 | 168 | 283 | 586 | ||||||||||||||
| Non-Current Liabilities | CHF mil | 72.0 | 19.5 | 48.5 | 164 | 374 | ||||||||||||||
| Current Liabilities | CHF mil | 88.7 | 138 | 119 | 119 | 213 | ||||||||||||||
| Net Debt/EBITDA | 2.05 | 13.9 | 4.47 | 5.90 | -16.8 | |||||||||||||||
| Net Debt/Equity | % | 44.5 | 28.5 | -32.2 | -18.6 | 57.4 | ||||||||||||||
| Cost of Financing | % | ... | 4.25 | 4.40 | 6.73 | 2.10 | 1.50 | |||||||||||||
| cash flow | ||||||||||||||||||||
| Total Cash From Operations | CHF mil | 18.9 | -13.8 | -22.2 | -33.2 | -82.6 | ||||||||||||||
| Total Cash From Investing | CHF mil | -16.4 | -23.1 | -62.2 | -140 | -143 | ||||||||||||||
| Total Cash From Financing | CHF mil | 2.50 | 37.0 | 166 | 297 | 200 | ||||||||||||||
| Net Change In Cash | CHF mil | 3.97 | 0.136 | 82.5 | 123 | -26.0 | ||||||||||||||
| valuation | ||||||||||||||||||||
| Market Capitalisation | USD mil | 72.3 | 320 | 832 | 758 | 961 | ||||||||||||||
| Enterprise Value (EV) | USD mil | 104 | 349 | 735 | 674 | 1,202 | ||||||||||||||
| Number Of Shares | mil | 3.21 | 3.55 | 5.51 | 6.35 | 8.66 | ||||||||||||||
| Share Price | CHF | 22.5 | 75.7 | 131 | 89.7 | 107 | ||||||||||||||
| Price/Earnings (P/E) | 21.0 | -21.0 | -18.9 | -14.6 | -17.7 | |||||||||||||||
| Price/Cash Earnings (P/CE) | 12.5 | -28.2 | -22.3 | -16.7 | -19.6 | |||||||||||||||
| EV/EBITDA | 6.54 | 165 | -34.5 | -47.2 | -84.8 | |||||||||||||||
| Price/Book Value (P/BV) | 0.992 | 2.59 | 2.45 | 1.28 | 2.29 | |||||||||||||||
| Dividend Yield | % | 0 | 0 | 0 | 0 | 0 |
| income statement | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| income statement | ||||||||||||||||||||
| Sales | CHF mil | 834 | 880 | 983 | 1,207 | 1,356 | ||||||||||||||
| Cost of Goods & Services | CHF mil | 709 | 748 | 835 | 1,026 | 1,147 | ||||||||||||||
| Gross Profit | CHF mil | 125 | 132 | 147 | 181 | 209 | ||||||||||||||
| Selling, General & Admin | CHF mil | 34.1 | 43.7 | 61.1 | 66.2 | 88.1 | ... | ... | ... | ... | ... | ... | ||||||||
| Research & Development | CHF mil | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | ||||||||
| Other Operating Expense | CHF mil | 666 | 707 | 810 | 977 | 1,120 | ... | ... | ... | ... | ... | ... | ||||||||
| Staff Cost | CHF mil | 53.7 | 60.2 | 78.3 | 93.7 | 117 | ... | ... | ... | ... | ... | ... | ||||||||
| Other Operating Cost (Income) | CHF mil | 6.33 | 5.40 | 9.74 | 3.07 | 42.0 | ... | ... | ... | ... | ... | ... | ||||||||
| EBITDA | CHF mil | 15.8 | 2.12 | -21.2 | -14.0 | -13.8 | ||||||||||||||
| Depreciation | CHF mil | 2.33 | 3.25 | 3.85 | 4.92 | 5.10 | ||||||||||||||
| EBIT | CHF mil | 8.44 | -7.09 | -38.3 | -32.9 | -45.7 | ||||||||||||||
| Net Financing Cost | CHF mil | 2.30 | 2.47 | 2.30 | 1.46 | 4.35 | ||||||||||||||
| Financing Cost | CHF mil | 2.47 | 2.48 | 2.30 | 1.70 | 4.40 | ||||||||||||||
| Financing Income | CHF mil | 0.165 | 0.013 | 0 | 0.237 | 0.051 | ||||||||||||||
| FX (Gain) Loss | CHF mil | 1.47 | 0.404 | -4.28 | 3.89 | -1.34 | ||||||||||||||
| (Income) / Loss from Affiliates | CHF mil | 0.716 | 0.630 | -0.134 | -0.173 | -0.031 | ... | ... | ... | ... | ... | ... | ||||||||
| Extraordinary Cost | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| Pre-Tax Profit | CHF mil | 4.04 | -12.7 | -36.5 | -38.5 | -50.1 | ||||||||||||||
| Tax | CHF mil | 0.598 | 0.053 | -0.241 | 0.553 | 2.27 | ||||||||||||||
| Minorities | CHF mil | 0 | 0 | -0.027 | -0.129 | -0.018 | ||||||||||||||
| Net Profit | CHF mil | 3.45 | -12.8 | -36.2 | -39.0 | -52.4 | ||||||||||||||
| Net Profit Avail. to Common | CHF mil | 3.45 | -12.8 | -36.2 | -39.0 | -52.4 | ||||||||||||||
| Dividends | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| growth rates | ||||||||||||||||||||
| Total Revenue Growth | % | ... | -8.86 | 5.41 | 11.8 | 22.8 | 12.3 | |||||||||||||
| Operating Cost Growth | % | ... | -8.80 | 7.17 | 15.6 | 20.6 | 16.1 | ... | ... | ... | ... | ... | ... | |||||||
| Staff Cost Growth | % | ... | -7.08 | 12.0 | 30.2 | 19.6 | 25.4 | ... | ... | ... | ... | ... | ... | |||||||
| EBITDA Growth | % | ... | -8.88 | -86.6 | -1,098 | -33.9 | -1.16 | |||||||||||||
| EBIT Growth | % | ... | 2.81 | -184 | 440 | -14.2 | 39.1 | |||||||||||||
| Pre-Tax Profit Growth | % | ... | -10.5 | -415 | 187 | 5.59 | 30.0 | |||||||||||||
| Net Profit Growth | % | ... | -51.8 | -471 | 184 | 7.54 | 34.4 | |||||||||||||
| ratios | ||||||||||||||||||||
| ROE | % | ... | 4.59 | -14.5 | -18.2 | -10.6 | -12.3 | |||||||||||||
| ROA | % | ... | 1.49 | -5.16 | -10.0 | -6.56 | -6.09 | |||||||||||||
| ROCE | % | ... | 2.63 | -9.22 | -17.8 | -12.1 | -9.90 | |||||||||||||
| Gross Margin | % | 15.0 | 15.0 | 15.0 | 15.0 | 15.4 | ||||||||||||||
| EBITDA Margin | % | 1.89 | 0.241 | -2.16 | -1.16 | -1.02 | ||||||||||||||
| EBIT Margin | % | 1.01 | -0.806 | -3.90 | -2.72 | -3.37 | ||||||||||||||
| Net Margin | % | 0.413 | -1.45 | -3.69 | -3.23 | -3.86 | ||||||||||||||
| Payout Ratio | % | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| Cost of Financing | % | ... | 4.25 | 4.40 | 6.73 | 2.10 | 1.50 | |||||||||||||
| Net Debt/EBITDA | 2.05 | 13.9 | 4.47 | 5.90 | -16.8 |
| balance sheet | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| balance sheet | ||||||||||||||||||||
| Cash & Cash Equivalents | CHF mil | 25.5 | 25.4 | 108 | 231 | 205 | ||||||||||||||
| Receivables | CHF mil | 72.5 | 71.4 | 84.0 | 92.3 | 127 | ||||||||||||||
| Unbilled Revenues | CHF mil | ... | ... | ... | ... | ... | ... | ... | ... | 4.72 | 3.93 | 0.415 | ||||||||
| Inventories | CHF mil | 34.8 | 48.3 | 59.3 | 69.4 | 70.6 | ||||||||||||||
| Other ST Assets | CHF mil | 9.49 | 14.6 | 17.5 | 20.3 | 25.4 | ||||||||||||||
| Current Assets | CHF mil | 142 | 160 | 273 | 417 | 428 | ||||||||||||||
| Property, Plant & Equipment | CHF mil | 26.2 | 26.2 | 29.7 | 34.3 | 77.1 | ||||||||||||||
| LT Investments & Receivables | CHF mil | 0.697 | 1.83 | 0.981 | 1.08 | 6.16 | ||||||||||||||
| Intangible Assets | CHF mil | 53.7 | 63.1 | 148 | 265 | 465 | ||||||||||||||
| Goodwill | CHF mil | 10.5 | 10.4 | 83.1 | 172 | 335 | ||||||||||||||
| Non-Current Assets | CHF mil | 91.1 | 102 | 188 | 310 | 564 | ||||||||||||||
| Total Assets | CHF mil | 233 | 262 | 462 | 727 | 992 | ||||||||||||||
| Trade Payables | CHF mil | 72.2 | 70.7 | 75.3 | 83.1 | 92.1 | ||||||||||||||
| Short-Term Debt | CHF mil | 0.500 | 50.0 | 10.4 | 3.52 | 87.4 | ||||||||||||||
| Other ST Liabilities | CHF mil | 3.06 | 3.75 | 13.0 | 9.53 | 6.92 | ||||||||||||||
| Current Liabilities | CHF mil | 88.7 | 138 | 119 | 119 | 213 | ||||||||||||||
| Long-Term Debt | CHF mil | 57.4 | 5.00 | 2.85 | 145 | 350 | ||||||||||||||
| Other LT Liabilities | CHF mil | 14.6 | 14.5 | 45.6 | 19.2 | 23.4 | ||||||||||||||
| Non-Current Liabilities | CHF mil | 72.0 | 19.5 | 48.5 | 164 | 374 | ||||||||||||||
| Liabilities | CHF mil | 161 | 158 | 168 | 283 | 586 | ||||||||||||||
| Preferred Equity and Hybrid Capital | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| Share Capital | CHF mil | 18.7 | 24.9 | 35.8 | 48.1 | 262 | ||||||||||||||
| Treasury Stock | CHF mil | 1.03 | 0.903 | 1.22 | 5.45 | 5.22 | ||||||||||||||
| Equity Before Minority Interest | CHF mil | 72.8 | 104 | 294 | 444 | 406 | ||||||||||||||
| Minority Interest | CHF mil | 0 | 0 | 0.219 | 0.030 | -0.110 | ||||||||||||||
| Equity | CHF mil | 72.8 | 104 | 294 | 444 | 406 | ||||||||||||||
| growth rates | ||||||||||||||||||||
| Total Asset Growth | % | ... | 2.33 | 12.0 | 76.6 | 57.3 | 36.5 | |||||||||||||
| Shareholders' Equity Growth | % | ... | -5.91 | 42.6 | 183 | 50.8 | -8.58 | |||||||||||||
| Net Debt Growth | % | ... | -11.9 | -8.72 | -420 | -12.8 | -382 | |||||||||||||
| Total Debt Growth | % | ... | -0.601 | -5.09 | -75.9 | 1,019 | 195 | |||||||||||||
| ratios | ||||||||||||||||||||
| Total Debt | CHF mil | 57.9 | 55.0 | 13.2 | 148 | 438 | ||||||||||||||
| Net Debt | CHF mil | 32.4 | 29.6 | -94.7 | -82.6 | 233 | ||||||||||||||
| Working Capital | CHF mil | 35.1 | 48.9 | 68.0 | 78.6 | 105 | ||||||||||||||
| Capital Employed | CHF mil | 126 | 151 | 256 | 388 | 669 | ||||||||||||||
| Net Debt/Equity | % | 44.5 | 28.5 | -32.2 | -18.6 | 57.4 | ||||||||||||||
| Current Ratio | 1.60 | 1.16 | 2.30 | 3.50 | 2.01 | |||||||||||||||
| Quick Ratio | 1.11 | 0.700 | 1.61 | 2.72 | 1.56 |
| cash flow | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| cash flow | ||||||||||||||||||||
| Net Profit | CHF mil | 3.45 | -12.8 | -36.2 | -39.0 | -52.4 | ||||||||||||||
| Depreciation | CHF mil | 2.33 | 3.25 | 3.85 | 4.92 | 5.10 | ||||||||||||||
| Non-Cash Items | CHF mil | 0.631 | 4.67 | 2.62 | 5.26 | -34.9 | ||||||||||||||
| Change in Working Capital | CHF mil | 7.43 | -14.9 | -5.73 | -18.4 | -27.2 | ||||||||||||||
| Total Cash From Operations | CHF mil | 18.9 | -13.8 | -22.2 | -33.2 | -82.6 | ||||||||||||||
| Capital Expenditures | CHF mil | -15.2 | -19.9 | -21.6 | -31.5 | -41.5 | ||||||||||||||
| Net Change in LT Investment | CHF mil | -0.272 | -1.28 | -0.121 | -0.450 | -3.21 | ||||||||||||||
| Net Cash From Acquisitions | CHF mil | -0.904 | -2.15 | -40.9 | -109 | -103 | ||||||||||||||
| Other Investing Activities | CHF mil | 0 | 0.261 | 0.432 | 0.244 | 4.62 | ||||||||||||||
| Total Cash From Investing | CHF mil | -16.4 | -23.1 | -62.2 | -140 | -143 | ||||||||||||||
| Dividends Paid | CHF mil | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| Issuance Of Shares | CHF mil | 0.034 | 42.5 | 222 | 185 | 0.495 | ||||||||||||||
| Issuance Of Debt | CHF mil | 4.39 | -3.87 | -56.1 | 112 | 200 | ||||||||||||||
| Other Financing Activities | CHF mil | -1.92 | -1.64 | 0 | 0 | -0.314 | ||||||||||||||
| Total Cash From Financing | CHF mil | 2.50 | 37.0 | 166 | 297 | 200 | ||||||||||||||
| Effect of FX Rates | CHF mil | -0.999 | 0.037 | 1.07 | -0.624 | -0.450 | ||||||||||||||
| Net Change In Cash | CHF mil | 3.97 | 0.136 | 82.5 | 123 | -26.0 | ||||||||||||||
| ratios | ||||||||||||||||||||
| Days Sales Outstanding | days | 31.7 | 29.6 | 31.2 | 27.9 | 34.1 | ||||||||||||||
| Days Sales Of Inventory | days | 17.9 | 23.6 | 25.9 | 24.7 | 22.5 | ||||||||||||||
| Days Payable Outstanding | days | 37.1 | 34.5 | 32.9 | 29.6 | 29.3 | ||||||||||||||
| Cash Conversion Cycle | days | 12.5 | 18.7 | 24.2 | 23.0 | 27.3 | ||||||||||||||
| Cash Earnings | CHF mil | 5.78 | -9.52 | -32.4 | -34.1 | -47.3 | ||||||||||||||
| Free Cash Flow | CHF mil | 2.47 | -36.9 | -84.4 | -174 | -226 | ||||||||||||||
| Capital Expenditures (As % of Sales) | % | 1.82 | 2.27 | 2.20 | 2.61 | 3.06 |
| other ratios | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| Employees | 716 | 752 | 1,106 | 1,314 | 1,710 | ... | ... | ... | ... | ... | ... | |||||||||
| Cost Per Employee | USD per month | 6,299 | 6,640 | 5,928 | 6,062 | 5,863 | ... | ... | ... | ... | ... | ... | ||||||||
| Cost Per Employee (Local Currency) | CHF per month | 6,255 | 6,667 | 5,903 | 5,942 | 5,726 | ... | ... | ... | ... | ... | ... | ||||||||
| Women (As % of Workforce) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Women (As % of Management) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | |
| Operating Cost (As % of Sales) | % | 99.7 | 101 | 105 | 103 | 106 | ... | ... | ... | ... | ... | ... | ||||||||
| Research & Development (As % of Sales) | % | 0 | 0 | 0 | 0 | 0 | ... | ... | ... | ... | ... | ... | ||||||||
| Staff Cost (As % of Sales) | % | 6.44 | 6.84 | 7.97 | 7.76 | 8.67 | ... | ... | ... | ... | ... | ... | ||||||||
| Effective Tax Rate | % | 14.8 | -0.417 | 0.660 | -1.43 | -4.52 | ||||||||||||||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 11.3 | 12.5 | 13.4 | 5.80 | 8.16 | |||||||||
| Total Revenue Growth (10-year average) | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 9.89 | ||||||||
| Customers | mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | 6.00 | 7.08 |
| valuation | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| Market Capitalisation | USD mil | 72.3 | 320 | 832 | 758 | 961 | ||||||||||||||
| Enterprise Value (EV) | USD mil | 104 | 349 | 735 | 674 | 1,202 | ||||||||||||||
| Number Of Shares | mil | 3.21 | 3.55 | 5.51 | 6.35 | 8.66 | ||||||||||||||
| Share Price | CHF | 22.5 | 75.7 | 131 | 89.7 | 107 | ||||||||||||||
| EV/EBITDA | 6.54 | 165 | -34.5 | -47.2 | -84.8 | |||||||||||||||
| Price/Earnings (P/E) | 21.0 | -21.0 | -18.9 | -14.6 | -17.7 | |||||||||||||||
| Price/Cash Earnings (P/CE) | 12.5 | -28.2 | -22.3 | -16.7 | -19.6 | |||||||||||||||
| P/FCF | 29.2 | -7.27 | -8.55 | -3.28 | -4.11 | ... | ||||||||||||||
| Price/Book Value (P/BV) | 0.992 | 2.59 | 2.45 | 1.28 | 2.29 | |||||||||||||||
| Dividend Yield | % | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| Free Cash Flow Yield | % | 3.44 | -11.5 | -10.2 | -23.3 | -24.0 | ||||||||||||||
| Earnings Per Share (EPS) | CHF | 1.07 | -3.60 | -6.94 | -6.14 | -6.04 | ||||||||||||||
| Cash Earnings Per Share | CHF | 1.80 | -2.68 | -5.88 | -5.36 | -5.45 | ||||||||||||||
| Free Cash Flow Per Share | CHF | 0.770 | -10.4 | -15.3 | -27.3 | -26.1 | ||||||||||||||
| Book Value Per Share | CHF | 22.7 | 29.3 | 53.4 | 69.9 | 46.8 | ||||||||||||||
| Dividend Per Share | CHF | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
| EV/Sales | 0.124 | 0.398 | 0.744 | 0.548 | 0.866 | |||||||||||||||
| EV/EBIT | 12.2 | -49.4 | -19.1 | -20.1 | -25.7 | |||||||||||||||
| EV/Free Cash Flow | 41.8 | -9.48 | -8.67 | -3.81 | -5.20 | ... | ||||||||||||||
| EV/Capital Employed | 0.843 | 2.36 | 2.80 | 1.71 | 1.74 | |||||||||||||||
| Earnings Per Share Growth | % | ... | -52.0 | -436 | 92.8 | -11.5 | -1.63 | |||||||||||||
| Cash Earnings Per Share Growth | % | ... | -38.5 | -249 | 119 | -8.75 | 1.68 | |||||||||||||
| Book Value Per Share Growth | % | ... | -5.77 | 29.0 | 82.4 | 30.9 | -33.0 | |||||||||||||
| Market Value per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | 126 | 136 | ||||||||
| Sales per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | 205 | 196 | ||||||||
| EBITDA per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | -2.38 | -2.00 | ||||||||
| Net Profit per Customer | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | -6.63 | -7.58 |
| clients & arpu | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
| Customers | mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | 6.00 | 7.08 | ||||||||
| Basket Size (USD) | USD | ... | ... | ... | ... | ... | ... | ... | ... | ... | 71.5 | 64.6 | ... | ... | ... | ... | ... | ... | ||
| Order Frequency | ... | ... | ... | ... | ... | ... | ... | ... | ... | 2.60 | 2.40 | ... | ... | ... | ... | ... | ... | |||
| Repeat Order Rate | % | ... | ... | ... | ... | ... | ... | ... | 84.0 | 87.0 | 81.0 | 79.0 | ... | ... | ... | ... | ... | ... | ||
| Site Visits | mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | 146 | 216 | ... | ... | ... | ... | ... | ... | ||
| Marketing Expenses | CHF mil | ... | ... | ... | ... | ... | ... | ... | 22.2 | 33.7 | 41.3 | 53.2 | ... | ... | ... | ... | ... | ... | ||
| Marketing Expenses (As % of Sales) | % | ... | ... | ... | ... | ... | ... | ... | 2.53 | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Get all company financials in excel:
By Helgi Analytics - October 8, 2022
Zur Rose made a net profit of CHF -226 mil with revenues of CHF 1,727 mil in 2021, down by 66.4% and up by 16.9%, respectively, compared to the previous year. This translates into a net margin of -13.1%. On the operating level, EBITDA reached CHF -143 mil, ...
By Helgi Analytics - October 8, 2022
Zur Rose invested a total of CHF 63.5 mil in 2021, up 6.1% compared to the previous year. Historically, between 2009 - 2021, the company's investments stood at a high of CHF 63.5 mil in 2021 and a low of CHF 1.73 mil in 2009. As a per...
By Helgi Analytics - October 8, 2022
Zur Rose made a net profit of CHF -226 mil in 2021, down 66.4% compared to the previous year. Historically, between 2009 and 2021, the company's net profit reached a high of CHF 40.6 mil in 2009 and a low of CHF -226 mil in 2021. The result implies a retu...
By Helgi Analytics - October 8, 2022
Zur Rose stock traded at CHF 236 per share at the end 2021 implying a market capitalization of USD 2,648 mil. Since the end of 2016, stock has appreciated by 211% implying an annual average growth of 25.5% In absolute terms, the value of the company rose...
By Helgi Analytics - October 8, 2022
Zur Rose made a net profit of CHF -226 mil with revenues of CHF 1,727 mil in 2021, down by 66.4% and up by 16.9%, respectively, compared to the previous year. This translates into a net margin of -13.1%. Historically, between 2009 and 2021, the firm...
By Helgi Analytics - October 8, 2022
Zur Rose's net debt stood at CHF 291 mil and accounted for 60.0% of equity at the end of 2021. The ratio is up 9.29 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 60.0% in 2021 and a low of -32...
By Helgi Analytics - October 8, 2022
Zur Rose stock traded at CHF 236 per share at the end 2021 translating into a market capitalization of USD 2,648 mil. Since the end of 2016, the stock has appreciated by 211% representing an annual average growth of 25.5%. At the end of 2021, the firm tr...
By Helgi Analytics - August 3, 2020
Zur Rose made a net profit of CHF -17.6 mil with revenues of CHF 344 mil in 4Q2019, down by 64.3% and up by 13.7%, respectively, compared to the previous year. This translates into a net margin of -5.13%. On the operating level, EBITDA reached CHF -5.69 m...
By Helgi Analytics - August 3, 2020
Zur Rose's operating cash flow stood at CHF -33.6 mil in 4Q2019, down 239% when compared to the previous year. Historically, between 1Q2009 - 4Q2019, the firm’s operating cash flow reached a high of CHF 5.23 mil in 3Q2012 and a low of CHF -33.6 mil ...
By Helgi Analytics - October 12, 2020
Zur Rose's total assets reached CHF 992 mil at the end of 4Q2019, up 36.5% compared to the previous year. Current assets amounted to CHF 428 mil, or 43.2% of total assets while cash stood at CHF 205 mil at the end of 4Q2019. ...
The Swiss Zur Rose Group is Europe’s largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. The Company also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany’s best-known pharmacy brand DocMorris. Zur Rose employs more than 1,800 people at sites in Switzerland, Germany, the Netherlands, Spain and France. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Zur Rose has been growing its sales by 13.1% a year on average in the last 5 years. EBITDA has grown by 305% during that time to total of CHF 182 mil in 2027, or 5.98% of sales. That’s compared to 3.04% average margin seen in last five years.
The company netted CHF 67.2 mil in 2027 implying ROE of 29.6% and ROCE of 6.43%. Again, the average figures were -3.92% and -1.68%, respectively when looking at the previous 5 years.
Zur Rose’s net debt amounted to CHF 575 mil at the end of 2027, or 221% of equity. When compared to EBITDA, net debt was 3.17x, up when compared to average of -0.589x seen in the last 5 years.
Zur Rose stock traded at CHF 27.1 per share at the end of 2027 resulting in a market capitalization of USD 298 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 4.67x and price to earnings (PE) of 4.05x as of 2027.
Helgi Analytics 
